For more detailed reviews on PI3K inhibitors targeting cancer stroma with a focus on immune modulation we refer readers to Okkenhaug et al. 2016 [28], and Vanhaesebroeck et al. 2022 [29]. The gene discussed is PIK3CD; the disease is cancer.